About Dali Pharmaceutical Company

The company was restructured and established in October 1996, and changed to a foreign-invested company limited by shares in January 2008. On September 22, 2017, the company's initial public offering of A-shares was officially listed on the main board of the Shanghai Stock Exchange. It became the first company listed on the A-share main board in Dali Prefecture and one of the few listed pharmaceutical companies in Yunnan Province. The company's main business is the production and sale of traditional Chinese medicine injections and the commercial distribution of pharmaceuticals. The company's main products are “Zhongjing” Xinming Injection and Shenmai Injection, and the “Zhongjing Zhongjing and Figure” trademark is a well-known trademark in China. Company honors include: Innovative Enterprises in Yunnan Province, Excellent Industrial Enterprises in Yunnan Province, Clean Production Enterprises, and Advanced Quality and Efficiency Enterprises in Yunnan Province.